Quality of life in pediatric patients after completion of antitumor therapy for malignant neoplasms of the kidneys

Introduction. The number of children and adolescents cured of malignant neoplasms (MN) is growing worldwide. An important task of modern pediatric oncology is to maintain quality of life (QOL) after the end of intensive antitumor therapy.

The aim of the study was to study the QOL of patients with MN of the kidneys at the stages of rehabilitation.

Results and discussion. Patients and parents filled out the relevant forms of the PedsQuality of Life Inventory Generic Core Scales (PedsQL) general quality of Life assessment questionnaire. A comparative analysis of the patientsʼ QOL was performed depending on the age of the patients at the time of the disease, the duration of remission, and the type of renal insufficiency.

Conclusions. The QOL assessment technique confirms the effectiveness of rehabilitation technologies in patients with renal insufficiency; after rehabilitation treatment, regardless of the type of tumor, an increase in QOL parameters is noted. The QOL estimates made by parents of patients with Wilms tumor (WT) are lower than those in pediatric forms of PedsQL, regardless of the volume of the tumor lesion and the age of the patients. The lowest QOL is observed in WT patients in the first 3 years after the end of antitumor therapy, which should motivate specialists and parents to start rehabilitation as early as possible. On 10–12 years of follow-up, QOL indicators decrease, probably due to the cumulative effect of other medical and social risk factors, preventing the achievement of the population level of QOL.

1. Rykov M.Yu. Lectures on pediatric oncology for students of medical universities. Sechenov University. M., 2019. (In Russ.).

2. Spreafico F., Fernandez C.V., Brok J., Nakata K., Nakata K., Vujanic G., Geller J.I., Gessler M., Maschietto M., Behjati S., Polanco A., Paintsil V., Luna-Fineman S., Pritchard-Jones K. Wilms tumour. Nat Rev Dis Primers. 2021;7(1):75. doi: 10.1038/s41572-021-00308-8.

3. Zdrojowy R., Sawicz-Birkowska K., Apoznański W., Patkowski D., Szydełko T., Pietras W., Dembowski J. Adult Wilms tumour. Int Urol Nephrol. 2011;43(3):691–6. doi: 10.1007/s11255-010-9868-7.

4. Francis D., Olsen N.J. Adult nephroblastoma. Scand J Urol Nephrol. 1977;11(3):305–8. doi: 10.3109/00365597709179971.

5. Radvanský J., Slabý K., Radvanská J., Malis J., Eckschalger T., Sulc J., Safárová M., Kolský A., Procházka M., Gilík J. Pozdní následky Wilmsova tumoru a jeho lécby u pacientů lécených v letech 1980–2001 na jediném pracovisti [Late effect of treatment of nephroblastoma in patients treated in 1980–2001 in a single center]. Klin Onkol. 2010;23(4):245–55.

6. Huang I.-C., Thompson L.A., Chi Y.-Y., Knapp C.A., Revicki D.A., Seid M., Shenkman E.A. The Linkage between Pediatric Quality of Life and Health Conditions: Establishing Clinically Meaningful Cutoff Scores for the PedsQL. Value Health. 2009;12(5):773–81. doi: 10.1111/j.1524-4733.2008.00487.x.

7. Saha H., Ghosh D., Biswas S.K., Mishra P.K., Saha K., Chatterjee U. Synchronous Bilateral Wilms Tumor: Five-Year Single-Center Experience with Assessment of Quality of Life. J Indian Assoc Pediatr Surg. 2019;24(1):52–60. doi: 10.4103/jiaps.JIAPS_42_18.

8. Cozzi D.A., Ceccanti S., Frediani S., Schiavetti A., Cozzi F. Chronic kidney disease in children with unilateral renal tumor. J Urol. 2012;187(5):1800–5. doi: 10.1016/j.juro.2011.12.109.

9. Bernal S.S., Vallejo O.G., Sánchez Sánchez A., Hernández C.M., Berrío J.R., Parra Gelderet B.A. Late effects of Wilmsʼ tumor treatment. Cir Pediatr. 2024;37(3):116–22. doi: 10.54847/cp.2024.03.13.

10. Mulder R.L., Hudson M.M., Bhatia S., Landier W., Levitt G., Constine L.S., Wallace W.H., van Leeuwen F.E., Ronckers C.M., Henderson T.O., Moskowitz C.S., Friedman D.N., Ng A.K., Jenkinson H.C., Demoor-Goldschmidtet C., Skinner R., Kremer L., Oeffinge K.C. Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer from the International Guideline Harmonization Group. J Clin Oncol. 2020;38(35):4194–207. doi: 10.1200/JCO.20.00562.

11. Knijnenburg S.L., Mulder R.L., Schouten-Van Meeteren A.Y., Bökenkamp A., Blufpand H., van Dulmen-den Broeder E., Veening M.A., Kremer L., Jaspers M. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2013;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2.

12. Oberlin O., Fawaz O., Rey A., Niaudet P., Ridola V., Orbach D., Bergeron C., Defachelles A.S., Gentet J-C., Schmitt C., Rubie H., Munzer M., Plantaz D., Deville A., Minard V., Corradini N., Leverger G., de Vathaire F. Long-term evaluation of Ifosfamiderelated nephrotoxicity in children. J Clin Oncol. 2009;27(32):5350–5. doi: 10.1200/JCO.2008.17.5257.

13. Schiavetti A., Altavista P., De Luca L., Andreoli G., Megaro G., Versacci P. Long-term renal function in unilateral non-syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols. Pediatr Blood Cancer. 2015;62(9):1637–44. doi: 10.1002/pbc.25558.

14. Mouelhi Y., Jouve E., Castelli C., Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcom. 2020;18:136. doi: 10.1186/s12955-020-01344-w.

15. Nikitina T.P., Ionova T.I. Actual aspects of quality of life research in pediatrics. Pediatricheskiy vestnik Yuzhnogo Urala = Pediatric Bulletin of the Southern Urals. 2022;(1):4–18. (In Russ.). doi: 10.34710/Chel.2022.94.65.002.

16. Moiseenko E.I., Nikitina T.P., Kurbatova K.A., Ionova T.I. Quality of life indicators in children in cancer remission and in their parents. Vestnik Mezhnatsionalʼnogo tsentra issledovaniya kachestva zhizni = Bulletin of the Interethnic Center for Quality of Life Research. 2013;21–22:91–103. (In Russ.).

17. Tseitlin G.Ya., Kokoreva M.E., Karelin A.F., Nikitina T.P., Porfirieva N.M., Zinkovskaya A.V., Ionova T.I. Quality of life of children with brain tumors and their parents after medical and social rehabilitation. Vestnik Mezhnatsionalʼnogo tsentra issledovaniya kachestva zhizni = Bulletin of the Interethnic Center for Quality of Life Research. 2019;33–34:7–18. (In Russ.).